Compare, Analyse Sanofi India with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   ACTAVIS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-21
ACTAVIS
Dec-18
SANOFI INDIA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs9,30015,288-   
Low Rs7,34410,255-   
Sales per share (Unadj.) Rs1,283.83,750.2-  
Earnings per share (Unadj.) Rs410.1-1,208.0-  
Cash flow per share (Unadj.) Rs439.0395.2-  
Dividends per share (Unadj.) Rs490.000-  
Avg Dividend yield %5.90-  
Book value per share (Unadj.) Rs940.315,468.0-  
Shares outstanding (eoy) m23.03332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.53.4 190.3%   
Avg P/E ratio x20.3-10.6 -191.9%  
P/CF ratio (eoy) x19.032.3 58.7%  
Price / Book Value ratio x8.90.8 1,071.9%  
Dividend payout %119.50-   
Avg Mkt Cap Rs m191,6614,247,956 4.5%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m4,3390-   
Avg. sales/employee Rs Th073,806.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-23,773.1-  
INCOME DATA
Net Sales Rs m29,5661,247,331 2.4%  
Other income Rs m74623,853 3.1%   
Total revenues Rs m30,3121,271,184 2.4%   
Gross profit Rs m12,51532,686 38.3%  
Depreciation Rs m667533,207 0.1%   
Interest Rs m1871,978 0.0%   
Profit before tax Rs m12,576-548,645 -2.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0139,927 0.0%   
Tax Rs m3,132-6,953 -45.0%   
Profit after tax Rs m9,444-401,766 -2.4%  
Gross profit margin %42.32.6 1,615.3%  
Effective tax rate %24.91.3 1,965.2%   
Net profit margin %31.9-32.2 -99.2%  
BALANCE SHEET DATA
Current assets Rs m36,791511,590 7.2%   
Current liabilities Rs m22,908452,569 5.1%   
Net working cap to sales %47.04.7 992.4%  
Current ratio x1.61.1 142.1%  
Inventory Days Days18920 964.1%  
Debtors Days Days1866 26.6%  
Net fixed assets Rs m18,762141,191 13.3%   
Share capital Rs m2300-   
"Free" reserves Rs m21,4250-   
Net worth Rs m21,6555,144,657 0.4%   
Long term debt Rs m01,811,620 0.0%   
Total assets Rs m55,5538,042,270 0.7%  
Interest coverage x699.7-6.6 -10,565.2%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.2 343.1%   
Return on assets %17.0-4.1 -415.4%  
Return on equity %43.6-7.8 -558.4%  
Return on capital %58.2-4.8 -1,201.4%  
Exports to sales %00-   
Imports to sales %19.40-   
Net fx Rs m-1,8670-   
CASH FLOW
From Operations Rs m5,588445,624 1.3%  
From Investments Rs m6,308244,812 2.6%  
From Financial Activity Rs m-8,490-764,825 1.1%  
Net Cashflow Rs m3,406-74,017 -4.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 79.01 Rs / USD

Compare SANOFI INDIA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: PARNAX LAB  KILITCH DRUGS  ERIS LIFESCIENCES  MEDPLUS HEALTH SERVICES  SHAMROCK IND  

Yellow Ad

Advertisement

Free Registration Closes at 5pm Tomorrow

We are closing the free registrations to our exclusive 'One Stock Crorepati' MEGA summit at 5 pm tomorrow.

At this event, we will reveal the details of one smallcap stock that is showing all the signs of a potential crorepati stock.

Thousands of smart Indians have already claimed their seats for this MEGA summit. So, we urge you to book your free seat now because we have a limited capacity.

Claim your free seat now

Learn more



Today's Market

Sensex Ends 150 Points Lower, Nifty Falls Below 15,800; FMCG & Banking Stocks Witness Selling(Closing)

After opening deep in the red, Indian share markets recovered most of the losses as the session progressed but still ended on a negative note.

Related Views On News

Biggest Dividend Payouts Announced so far this Year... (Views On News)

May 25, 2022

These stocks have the highest dividend payout ratio in financial year 2022 so far. Do you have any of them in your portfolio?

SANOFI INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Dec 31, 2021

Here's an analysis of the annual report of SANOFI INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

Is it Time to Start Buying Stocks Selectively? (Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

The One Smallcap Stock I'll Recommend Now (Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

When Will the Stock Market Recover? (Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jun 29, 2022 03:32 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - KOPRAN. COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS